BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Business

  CymaBay Therapeutics To Report Second Quarter 2017 Financial Results On Thursday, August 10

  August 7, 2017

   · 

  1 min read
• Biotech Bay

  Cyanotech To Hold Investor Broadcast On Friday, August 11, 2017

  August 7, 2017

   · 

  2 min read
• Pharm Country

  Polaryx Therapeutics Receives Orphan Drug Designation From The U.S. FDA For PLX-200 For Rare Pediatric Disease

  August 7, 2017

   · 

  3 min read
• Business

  EyeGate Pharma Reports Second Quarter 2017 Financial Results And Provides Business Update

  August 7, 2017

   · 

  5 min read
• Business

  TG Therapeutics To Host Conference Call On Second Quarter 2017 Financial Results And Business Update

  August 7, 2017

   · 

  1 min read
• BioCapital

  FDA Updates on Getinge/Datascope IABP Recall, Labels as Class I

  August 7, 2017

   · 

  1 min read
• Business

  MYnd Analytics Adds Experienced Sales & Marketing Executive

  August 7, 2017

   · 

  3 min read
• Drug Development

  Rebiotix Announces First Patient Enrolled In Phase III Clinical Trial Of RBX2660 For The Prevention Of Recurrent Clostridium Difficile Infection

  August 7, 2017

   · 

  4 min read
• FDA

  CMP Pharma Announces FDA Approval Of CaroSpir (Spironolactone Oral Suspension, 25 Mg/5 mL)

  August 7, 2017

   · 

  3 min read
• Drug Development

  Biohaven Completes Randomization In Phase II/III Trial In Spinocerebellar Ataxia: Expected Topline Data Advanced To Fourth Quarter Of 2017

  August 7, 2017

   · 

  6 min read